287 related articles for article (PubMed ID: 19591781)
1. The search for lupus biomarkers.
Liu CC; Ahearn JM
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):507-23. PubMed ID: 19591781
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for systemic lupus erythematosus: a review and perspective.
Liu CC; Manzi S; Ahearn JM
Curr Opin Rheumatol; 2005 Sep; 17(5):543-9. PubMed ID: 16093831
[TBL] [Abstract][Full Text] [Related]
3. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for systemic lupus erythematosus.
Ahearn JM; Liu CC; Kao AH; Manzi S
Transl Res; 2012 Apr; 159(4):326-42. PubMed ID: 22424435
[TBL] [Abstract][Full Text] [Related]
5. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of autophagy-related genes in Egyptian systemic lupus erythematosus patients.
Kamel AM; Badary MS; Mohamed WA; Ahmed GH; El-Feky MA
Int J Rheum Dis; 2020 Aug; 23(9):1226-1232. PubMed ID: 32783391
[TBL] [Abstract][Full Text] [Related]
7. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.
Bauer JW; Petri M; Batliwalla FM; Koeuth T; Wilson J; Slattery C; Panoskaltsis-Mortari A; Gregersen PK; Behrens TW; Baechler EC
Arthritis Rheum; 2009 Oct; 60(10):3098-107. PubMed ID: 19790071
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.
Delongui F; Lozovoy MAB; Iriyoda TMV; Costa NT; Stadtlober NP; Alfieri DF; Flauzino T; Dichi I; Simão ANC; Reiche EMV
Clin Rheumatol; 2017 Aug; 36(8):1779-1788. PubMed ID: 28567557
[TBL] [Abstract][Full Text] [Related]
9. Promising biomarkers for systemic lupus erythematosus.
Jung JY; Bae CB; Suh CH
Expert Opin Med Diagn; 2013 Nov; 7(6):601-13. PubMed ID: 24099307
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
Kao AH; Navratil JS; Ruffing MJ; Liu CC; Hawkins D; McKinnon KM; Danchenko N; Ahearn JM; Manzi S
Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
[TBL] [Abstract][Full Text] [Related]
11. Serum thiols as a biomarker of disease activity in lupus nephritis.
Lalwani P; de Souza GK; de Lima DS; Passos LF; Boechat AL; Lima ES
PLoS One; 2015; 10(3):e0119947. PubMed ID: 25799079
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
Li J; An L; Zhang Z
Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
[TBL] [Abstract][Full Text] [Related]
13. Association between vitamin D receptor polymorphisms and systemic lupus erythematosus in an Indian cohort.
Mahto H; Tripathy R; Das BK; Panda AK
Int J Rheum Dis; 2018 Feb; 21(2):468-476. PubMed ID: 29230954
[TBL] [Abstract][Full Text] [Related]
14. Assessing association of common variation in the C1Q gene cluster with systemic lupus erythematosus.
Rafiq S; Frayling TM; Vyse TJ; Cunninghame Graham DS; Eggleton P
Clin Exp Immunol; 2010 Aug; 161(2):284-9. PubMed ID: 20528885
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus: The search for the ideal biomarker.
González LA; Ugarte-Gil MF; Alarcón GS
Lupus; 2021 Feb; 30(2):181-203. PubMed ID: 33307987
[TBL] [Abstract][Full Text] [Related]
16. CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study.
Panda AK; Tripathy R; Das BK
Lupus; 2021 Feb; 30(2):219-227. PubMed ID: 33176568
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and Systemic Lupus Erythematosus: Unmet Needs.
Meroni PL; Penatti AE
Clin Rev Allergy Immunol; 2016 Jun; 50(3):367-76. PubMed ID: 26206675
[TBL] [Abstract][Full Text] [Related]
18. Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.
Lee YH; Song GG
Lupus; 2017 Feb; 26(2):132-138. PubMed ID: 27307447
[TBL] [Abstract][Full Text] [Related]
19. [Serum free light chains for monitoring systemic lupus erythematosus activity].
Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
[TBL] [Abstract][Full Text] [Related]
20. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E
Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
